Calypso Medical Technologies Announces First Post-Operative Prostatectomy Patient Implanted in Clinical Study to Track Tissue Motion during Radiation Therapy

SEATTLE & BOSTON--(BUSINESS WIRE)--Calypso Medical Technologies, Inc. today announced the initiation of its latest clinical study, the PROBE clinical study (Prostatic Bed Experience with the Calypso® 4D Localization System) to guide delivery of intensity modulated radiation therapy (IMRT) in prostate cancer patients following radical prostatectomy.